Diseases & Topics
Tuberculosis
North Carolina Tuberculosis Policy Manual
Memos
- Isoniazid shortage update, April 26, 2023 (256 KB PDF)
- Rifampin shortage update, May 10, 2022 (38 KB PDF)
- SARS-CoV-2 Vaccine and Tuberculosis Screening, January 28, 2021 (115 KB PDF)
- Memo TB Manual Revisions, October 27, 2020 (205 KB PDF)
- Memo Resumption Baseline TB Testing, September 25, 2020 (450 KB PDF)
- Memo Resolution of TB drug shortages, May 22, 2020 (22 KB PDF)
- Memo Deferring baseline tuberculosis screening for new hires, April 16, 2020 (34 KB PDF)
- Memo TB Medication shortages, March 24, 2020 (30 KB PDF)
- Memo Guidance for Video DOT during COVID-19 , March 16, 2020 (33 KB PDF)
|
| Chapter |
Title |
File Size |
Pages |
| |
Table of Contents |
155 KB |
9 |
| Chapter I |
Introduction |
182 KB |
8 |
| Chapter II |
Mantoux Tuberculin Skin Testing (TST) and Interferon Gamma Release Assays (IGRAS) |
419 KB |
28 |
| Chapter III |
Targeted Testing and Treatment of Latent Tuberculosis Infection (LTBI) |
460 KB |
32 |
| Chapter IV |
Diagnosis and Treatment of TB Disease
Individuals
|
559 KB |
40 |
| Chapter V |
TB and HIV/AIDS |
130 KB |
6 |
| Chapter VI |
Non-adherence |
214 KB |
14 |
| Chapter VII |
Drugs and Ordering |
94 KB |
4 |
| Chapter VIII |
Contact Investigation |
237 KB |
10 |
| Chapter IX |
American Lung Association Funds |
345 KB |
8 |
| Chapter X |
Selected Resources |
357 KB |
18 |
| Chapter XI |
Infection Control |
391 KB |
13 |
| Chapter XII |
Laboratory Services |
159 KB |
8 |
| Chapter XIII |
Class A and B Notification of Arrival |
98 KB |
4 |
| Chapter XIV |
TB Related Laws |
432 KB |
42 |
| Chapter XV |
Record Management |
96 KB |
4 |
